Ganji Purnachandra Nagaraju

20PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 03, 2026
Reprogramming the pancreatic ductal adenocarcinoma microenvironment: a novel integrin-targeted cytotoxin, ProAgio, potentiates chemotherapy.

|May 04, 2026
Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions.

|Sep 27, 2025
Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Jeremy Foote

|May 19, 2025
Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Bassel El-Rayes, Dhana Reddy, Sujith Sarvesh

|Jan 11, 2025
Effect of Gut Dysbiosis on Onset of GI Cancers.

Seema Kumari, Mundla Srilatha, Ganji Purnachandra Nagaraju

|Dec 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Jeremy B Foote, Tyler E Mattox, Adam B Keeton

Pageof 4

Frequent Collaborators

6 joint publications

Bassel F El-Rayes

3 joint publications

Dhana Sekhar Reddy Bandi

2 joint publications

Yuchen Zhang

1 joint publications

Seema Kumari